Several other studies have reported that levels of VCAM-1 are particularly increased in severe complications of SCD, including HbSS vaso-occlusive crises [7,8,9] and acute chest syndrome [10], and thus, may serve as a promising biomarker of disease severity and associated complications of SCD [9]. Here, VCAM1 is linked to acute chest syndrome.